Haseltine William A - Insider Stock Trading - OpenInsider

CIK: 938807 - Address: C/O Acasti Pharma Inc., 3009 Boul. De La Concorde East Suite 102, Laval, A6 H7T 2B5

9 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	9	-2	-6	-9	-10	-29	-15	-12
S	%wins				67	100	100	100	100	100	94

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
2/17/04 21:53	2/13/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-9	13.30	22	-1	0	2,822	M	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 21:37	2/13/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-98	13.00	22	-8	0	2,822	I	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 20:49	2/13/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-544	13.17	22	-41	-1	2,830	M	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 19:59	2/13/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-2,485	12.91	22	-192	-6	2,871	D	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 19:51	2/12/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S.a	-166	13.50	22	-12	0	3,064	M	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 16:22	2/12/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-166	13.50	22	-12	0	3,064	I	-54	98	-1	-4	-6	-9	-2	-7	-3	-6	-10	-10	-29	-15
2/17/04 15:16	2/12/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-3,407	13.45	22	-253	-8	3,076	M	-54	98	-1	-4	-6	-9	-2	-7	1	-5	-8	-9	-28	-14
2/17/04 13:12	2/12/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-312	13.30	22	-23	-1	3,329	I	-54	98	-1	-4	-6	-9	-2	-7	1	-5	-8	-9	-28	-14
2/17/04 11:37	2/12/04	HGSI	Human Genome Sciences Inc	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Haseltine William A	MD	DO	CB,CEO	S	-3,071	13.30	22	-231	-6	3,353	D	-54	98	-1	-4	-6	-9	-2	-7	1	-5	-8	-9	-28	-14

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact